Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice

JA Silvas, DM Vasquez, JG Park, K Chiem… - Journal of …, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral pathogen
responsible for the current coronavirus disease 2019 (COVID-19) pandemic. As of 19 May …

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions

Y Liu, X Zhang, J Liu, H Xia, J Zou, AE Muruato… - Nature …, 2022 - nature.com
We report a live-attenuated SARS-CoV-2 vaccine candidate with (i) re-engineered viral
transcription regulator sequences and (ii) deleted open-reading-frames (ORF) 3, 6, 7, and 8 …

Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2

L Zinzula - Biochemical and biophysical research communications, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome contains nine
open reading frames (ORFs) that encode for accessory proteins which, although …

SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice

ES Winkler, RE Chen, F Alam, S Yildiz, JB Case… - Journal of …, 2022 - Am Soc Microbiol
The development of mouse models for coronavirus disease 2019 (COVID-19) has enabled
testing of vaccines and therapeutics and defining aspects of severe acute respiratory …

Emerging SARS-CoV-2 variants expand species tropism to murines

H Shuai, JFW Chan, TTT Yuen, C Yoon, JC Hu… - …, 2021 - thelancet.com
Background Wildtype mice are not susceptible to SARS-CoV-2 infection. Emerging SARS-
CoV-2 variants, including B. 1.1. 7, B. 1.351, P. 1, and P. 3, contain mutations in spike that …

SARS-CoV-2 ORF8 forms intracellular aggregates and inhibits IFNγ-induced antiviral gene expression in human lung epithelial cells

H Geng, S Subramanian, L Wu, HF Bu… - Frontiers in …, 2021 - frontiersin.org
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
COVID-19, a disease that involves significant lung tissue damage. How SARS-CoV-2 …

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants

JJ Sims, JA Greig, KT Michalson, S Lian… - PLoS …, 2021 - journals.plos.org
SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and
escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal …

SARS-CoV-2 ORF8: a rapidly evolving immune and viral modulator in COVID-19

A Arduini, F Laprise, C Liang - Viruses, 2023 - mdpi.com
The COVID-19 pandemic has resulted in upwards of 6.8 million deaths over the past three
years, and the frequent emergence of variants continues to strain global health. Although …

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants

V Monteil, B Eaton, E Postnikova, M Murphy… - EMBO Molecular …, 2022 - embopress.org
The recent emergence of multiple SARS‐CoV‐2 variants has caused considerable concern
due to both reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It …

Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice

JP Natekar, H Pathak, S Stone, P Kumari, S Sharma… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the current
pandemic, resulting in millions of deaths worldwide. Increasingly contagious variants of …